The metabolic influence of progestins
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1971 |
|---|---|
| Erschienen: |
1971 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
Advances in metabolic disorders - 5(1971) vom: 26., Seite 119-47 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Landau, R L [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 16.09.1971 Date Revised 30.10.2019 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM049136615 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM049136615 | ||
| 003 | DE-627 | ||
| 005 | 20231221181001.0 | ||
| 007 | tu | ||
| 008 | 231221s1971 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0164.xml |
| 035 | |a (DE-627)NLM049136615 | ||
| 035 | |a (NLM)4934165 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Landau, R L |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The metabolic influence of progestins |
| 264 | 1 | |c 1971 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 16.09.1971 | ||
| 500 | |a Date Revised 30.10.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biology | |
| 650 | 4 | |a Carbohydrate Metabolic Effects | |
| 650 | 4 | |a Contraception | |
| 650 | 4 | |a Contraceptive Agents, Female--side effects | |
| 650 | 4 | |a Contraceptive Agents, Progestin--side effects | |
| 650 | 4 | |a Contraceptive Agents--side effects | |
| 650 | 4 | |a Contraceptive Methods--side effects | |
| 650 | 4 | |a Endocrine System | |
| 650 | 4 | |a Family Planning | |
| 650 | 4 | |a Hormones | |
| 650 | 4 | |a Lipid Metabolic Effects | |
| 650 | 4 | |a Lipids | |
| 650 | 4 | |a Metabolic Effects | |
| 650 | 4 | |a Norethindrone | |
| 650 | 4 | |a Norethynodrel | |
| 650 | 4 | |a Oral Contraceptives--side effects | |
| 650 | 4 | |a Physiology | |
| 650 | 4 | |a Progestational Hormones | |
| 650 | 4 | |a Progesterone | |
| 650 | 4 | |a Pulmonary Effects | |
| 650 | 4 | |a Respiratory Insufficiency | |
| 650 | 7 | |a Amino Acids |2 NLM | |
| 650 | 7 | |a Anabolic Agents |2 NLM | |
| 650 | 7 | |a Contraceptives, Oral |2 NLM | |
| 650 | 7 | |a Electrolytes |2 NLM | |
| 650 | 7 | |a Hydroxyprogesterones |2 NLM | |
| 650 | 7 | |a Mineralocorticoids |2 NLM | |
| 650 | 7 | |a Progestins |2 NLM | |
| 650 | 7 | |a Proteins |2 NLM | |
| 650 | 7 | |a Carbon Dioxide |2 NLM | |
| 650 | 7 | |a 142M471B3J |2 NLM | |
| 650 | 7 | |a Aldosterone |2 NLM | |
| 650 | 7 | |a 4964P6T9RB |2 NLM | |
| 650 | 7 | |a Growth Hormone |2 NLM | |
| 650 | 7 | |a 9002-72-6 |2 NLM | |
| 650 | 7 | |a Medroxyprogesterone |2 NLM | |
| 650 | 7 | |a HSU1C9YRES |2 NLM | |
| 650 | 7 | |a Pregnanediol |2 NLM | |
| 650 | 7 | |a JR3JD1Y22C |2 NLM | |
| 650 | 7 | |a Nitrogen |2 NLM | |
| 650 | 7 | |a N762921K75 |2 NLM | |
| 650 | 7 | |a Potassium |2 NLM | |
| 650 | 7 | |a RWP5GA015D |2 NLM | |
| 700 | 1 | |a Poulos, J T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advances in metabolic disorders |d 1964 |g 5(1971) vom: 26., Seite 119-47 |w (DE-627)NLM000779342 |x 0065-2903 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:1971 |g day:26 |g pages:119-47 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 1971 |b 26 |h 119-47 | ||